Fundraising Fox
DVLP Medicines
Founded 2022 · 11 employees on LinkedIn · 1 known investors
Find your way into DVLP Medicines
Sign up to see every warm intro you have to DVLP Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DVLP Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.
Founders & leadership
DVLP Medicines was founded in 2022 by Patrick Perry and Jason Paragas.
PP
Patrick PerryCo-founder / CFO / GMPatrick Perry served in investment management and business development roles, most recently at Geode Capital where he led institutional client relationships and helped grow assets under management across multiple asset classes. He is now co-founder and CFO of DVLP Medicines, a biotechnology company developing vaccine platforms.
Board
MK
Mehmood KhanChairman of the Board
Investors · 1
DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does DVLP Medicines do?
- DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.
- Who founded DVLP Medicines?
- DVLP Medicines was founded by Patrick Perry, Jason Paragas in 2022.
- Who are DVLP Medicines's investors?
- DVLP Medicines's investors include DCVC (Data Collective).